Literature DB >> 106732

In vitro and in vivo production of chemotactic inhibitors by tumor cells.

M C Cohen, J P Brozna, P A Ward.   

Abstract

The ascites fluid or peritoneal washings of DBA/2 mice bearing the P815 mastocytoma have been found to contain a chemotactic factor inactivator (CFI) which inactivates the bacterial chemotactic factor as well as the chemotactic activity associated with the C3 and C5 fragments when assayed on rabbit neutrophils. The amount of CFI is proportional to the number of tumor cells in the peritoneal exudate. The inactivator is also found in tumor cell hemogenates as well as in culture fluid from tumor cells growing in vitro. The activity is heat-labile but is not affected by protease inhibitors. Its molecular weight is greater than 50,000 daltons, based on Sephadex chromatography and sucrose density gradient ultracentrifugation studies. In C57BL/6 mice, which reject the mastocytoma, CFI levels decrease in proportion to the decreasing numbers of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 106732      PMCID: PMC2042254     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Serum-associated inhibition of leukotaxis in humans with cancer.

Authors:  E G Maderazo; T F Anton; P A Ward
Journal:  Clin Immunol Immunopathol       Date:  1978-02

2.  Chemotactic factor inactivators of human granulocytes.

Authors:  J P Brozna; R M Senior; D L Kreutzer; P A Ward
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

3.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

4.  Chemotaxis of polymorphonuclear leukocytes.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  1968-03       Impact factor: 5.858

5.  Antileukotactic properties of tumor cells.

Authors:  J P Brozna; P A Ward
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  The elastase activity of alveolar macrophages: measurements using synthetic substrates and elastin.

Authors:  E A Levine; R M Senior; J V Butler
Journal:  Am Rev Respir Dis       Date:  1976-01

7.  Regression of feline sarcoma virus-induced sarcomas in dogs. I. Morphologic investigations.

Authors:  D O Slauson; B I Osburn; M Shifrine; D L Dungworth
Journal:  J Natl Cancer Inst       Date:  1975-02       Impact factor: 13.506

8.  Chemotactic factor inactivator in normal human serum.

Authors:  J L Berenberg; P A Ward
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  Tumor cell threshold required for suppression of macrophage inflammation.

Authors:  S J Normann
Journal:  J Natl Cancer Inst       Date:  1978-05       Impact factor: 13.506

10.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

View more
  2 in total

Review 1.  [Importance of fibroblast chemotaxis in wound healing and tumor cell evasion].

Authors:  H Mensing
Journal:  Klin Wochenschr       Date:  1985-02-15

Review 2.  Macrophages and neoplasms: new insights and their implication in tumor immunobiology.

Authors:  R Evans
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.